Edition:
United Kingdom

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

511.85INR
11:17am BST
Change (% chg)

Rs11.00 (+2.20%)
Prev Close
Rs500.85
Open
Rs500.00
Day's High
Rs513.80
Day's Low
Rs498.05
Volume
785,298
Avg. Vol
856,041
52-wk High
Rs746.00
52-wk Low
Rs493.50

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Glenn Saldanha

47 2011 Executive Chairman of the Board, Chief Executive Officer, Managing Director

V. Mani

2017 President, Global Chief Financial Officer

Harish Kuber

2017 Compliance Officer, Company Secretary

Murali Neelakantan

2017 Executive Director - Global General Counsel, Executive Director

Cherylann Pinto

2017 Director - Corporate Affairs